GIP/GLP-1 receptor agonist
Tirzepatide companies
Answer
Public registers name 2 licence holders, 38 ingredient makers with a drug master file, 32 bulk ingredient labelers, 5 US labelers, 138 trial sponsors, 110 companies with an FDA warning letter and 6 recalling firms for Tirzepatide.
Each row is what a register states. A company named here is not endorsed or accused by this site.
MARKETING AUTHORISATION HOLDER
2 companies
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| ELI LILLY CANADA INC | MOUNJARO (DIN 02532891), Approved Regulator Health Canada MOUNJARO (DIN 02532905), Approved Regulator Health Canada MOUNJARO (DIN 02532913), Approved Regulator Health Canada and 21 more entries |
|---|---|
| Eli Lilly Nederland B.V. | Mounjaro (EMEA/H/C/005620), Authorised Regulator EMA MOUNJARO 10 MG KWIKPEN SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 14895/0343, Authorised Regulator MHRA MOUNJARO 10 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 14895/0321, Authorised Regulator MHRA and 16 more entries |
API MANUFACTURER
38 companies
Filed a drug master file with FDA for the active ingredient.
| ALEMBIC PHARMACEUTICALS LTD | DMF 43203, type II, active, submitted 2026-02-25 Regulator FDA drug master file list |
|---|---|
| ALLSINO PHARMACEUTICAL CO LTD | DMF 42448, type II, active, submitted 2025-08-22 Regulator FDA drug master file list DMF 42449, type II, active, submitted 2025-09-28 Regulator FDA drug master file list |
| ALP PHARM BEIJING CO LTD | DMF 38773, type II, active, submitted 2023-08-30 Regulator FDA drug master file list |
| APICORE US LLC | DMF 40123, type II, active, submitted 2024-07-27 Regulator FDA drug master file list |
| BIOCON LTD | DMF 43038, type II, active, submitted 2025-11-24 Regulator FDA drug master file list |
| CHANGZHOU PHARMACEUTICAL FACTORY | DMF 43153, type II, active, submitted 2025-11-28 Regulator FDA drug master file list |
| CHENGDU SHENGNUO BIOPHARM CO LTD | DMF 42445, type II, active, submitted 2025-11-26 Regulator FDA drug master file list |
| CHINESE PEPTIDE CO | DMF 43979, type II, active, submitted 2026-04-27 Regulator FDA drug master file list |
| DR REDDYS LABORATORIES LTD | DMF 43800, type II, active, submitted 2026-03-31 Regulator FDA drug master file list |
| EL-PEPTIDO (SHANGHAI) BIOPHARMACEUTICAL CO LTD | DMF 43426, type II, active, submitted 2025-12-29 Regulator FDA drug master file list |
| FUJIAN GENOHOPE BIOTECH LTD | DMF 40503, type II, active, submitted 2024-09-19 Regulator FDA drug master file list |
| GUIZHOU UTIDE BIOTECHNOLOGY CO LTD | DMF 42984, type II, active, submitted 2025-12-24 Regulator FDA drug master file list |
| HANGZHOU APEXTIDE BIOMEDICAL TECHNOLOGY CO LTD | DMF 40481, type II, active, submitted 2024-12-10 Regulator FDA drug master file list |
| HANGZHOU HOTIDE BIOTECH CO LTD | DMF 41744, type II, active, submitted 2025-10-31 Regulator FDA drug master file list |
| HANGZHOU THINHEAL PHARMA-TECH CO LTD | DMF 39900, type II, active, submitted 2024-06-28 Regulator FDA drug master file list |
| Harbin Jixianglong Biotech Co., Ltd. | DMF 39611, type II, active, submitted 2024-02-28 Regulator FDA drug master file list |
| HYBIO PHARMACEUTICAL CO LTD | DMF 40156, type II, active, submitted 2024-06-27 Regulator FDA drug master file list |
| JENKEM TECHNOLOGY CO LTD | DMF 40925, type II, active, submitted 2024-12-12 Regulator FDA drug master file list |
| MSN LIFE SCIENCES PRIVATE LTD | DMF 43540, type II, active, submitted 2026-02-11 Regulator FDA drug master file list |
| NANJING CELLNUO BIOPHARMACEUTICAL CO LTD | DMF 41650, type II, active, submitted 2025-03-28 Regulator FDA drug master file list |
| NANJING HANXIN PHARMACEUTICAL TECHNOLOGY CO LTD | DMF 40378, type II, active, submitted 2024-12-11 Regulator FDA drug master file list |
| NINGXIA LABSCHEM CO LTD | DMF 42259, type II, active, submitted 2025-07-03 Regulator FDA drug master file list |
| SHANGHAI JINGMAI PHARMACEUTICAL SCIENCE & TECHNOLOGY CO LTD | DMF 40166, type II, active, submitted 2024-06-27 Regulator FDA drug master file list |
| SHENZHEN ALVANTIS PHARMA CO LTD | DMF 40668, type II, active, submitted 2024-10-16 Regulator FDA drug master file list |
| SHENZHEN JYMED TECHNOLOGY CO LTD | DMF 40115, type II, active, submitted 2024-07-18 Regulator FDA drug master file list |
| SHENZHEN READLINE BIOTECH CO LTD | DMF 41461, type II, active, submitted 2025-03-16 Regulator FDA drug master file list |
| SICHUAN DUORUI BIOPHARMACEUTICAL CO LTD | DMF 43257, type II, active, submitted 2025-12-10 Regulator FDA drug master file list |
| SICHUAN JISHENG BIOPHARMACEUTICAL CO LTD | DMF 41523, type II, active, submitted 2025-03-19 Regulator FDA drug master file list |
| SICHUAN PUKANG PHARMACEUTICAL CO LTD | DMF 39989, type II, active, submitted 2024-06-28 Regulator FDA drug master file list |
| SICHUAN QISHENG BIOMEDICAL TECHNOLOGY CO LTD | DMF 40495, type II, active, submitted 2024-09-11 Regulator FDA drug master file list |
| SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD | DMF 39465, type II, active, submitted 2024-02-06 Regulator FDA drug master file list |
| SUZHOU MOTIF BIOTECH CO LTD | DMF 41036, type II, active, submitted 2025-01-03 Regulator FDA drug master file list |
| SUZHOU RYWAY BIOTECH CO LTD | DMF 41066, type II, active, submitted 2024-12-25 Regulator FDA drug master file list |
| SUZHOU TIANMA PHARMA GROUP TIANJI BIO-PHARMACEUTICAL CO LTD | DMF 44306, type II, active, submitted 2026-06-29 Regulator FDA drug master file list |
| TAPI NL BV | DMF 42369, type II, active, submitted 2025-12-15 Regulator FDA drug master file list |
| XIUSHI BIOPHARMA (NANTONG) CO LTD | DMF 43983, type II, active, submitted 2026-03-30 Regulator FDA drug master file list |
| YANGZHOU AURISCO PHARMACEUTICAL CO LTD | DMF 41816, type II, active, submitted 2025-12-31 Regulator FDA drug master file list |
| ZHEJIANG PEPTITES BIOTECH CO LTD | DMF 39655, type II, active, submitted 2024-03-17 Regulator FDA drug master file list DMF 42981, type II, active, submitted 2025-11-23 Regulator FDA drug master file list |
BULK INGREDIENT LABELER
32 companies
Lists the bulk active ingredient with FDA (NDC directory).
| Apicore pharmaceuticals private limited | Tirzepatide, BULK INGREDIENT Regulator openFDA |
|---|---|
| Assia Chemical Industries Ltd - Teva Tech Site | Tirzepatide, BULK INGREDIENT Regulator openFDA |
| Aurisco Pharmaceutical Co.,Ltd | Tirzepatide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
| Biocon Limited | TIRZEPATIDE, BULK INGREDIENT Regulator openFDA |
| BioVectra Inc. | Tirzepatide, BULK INGREDIENT Regulator openFDA |
| Chatnaa Life Sciences LLC | Tirzepatide, BULK INGREDIENT Regulator openFDA |
| CHENGDU SHENGNUO BIOPHARM CO LTD | tirzepatide, BULK INGREDIENT Regulator openFDA |
| CHONGQING SINTAHO PHARMACEUTICAL CO LTD | Tirzepatide, BULK INGREDIENT Regulator openFDA |
| CORDEN PHARMA COLORADO INC | Tirzepatide, BULK INGREDIENT Regulator openFDA |
| Darmerica, LLC | Tirzepatide, BULK INGREDIENT Regulator openFDA |
| EL-PEPTIDO (SHANGHAI) BIOPHARMACEUTICAL CO LTD | TIRZEPATIDE, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
| Eli Lilly & Company | tirzepatide, BULK INGREDIENT Regulator openFDA |
| FUJIAN GENOHOPE BIOTECH LTD | Tirzepatide, BULK INGREDIENT Regulator openFDA |
| Guangdong Longfu Medicine Co., Ltd. | TIRZEPATIDE, BULK INGREDIENT Regulator openFDA |
| HANGZHOU HOTIDE BIOTECH CO LTD | Tirzepatide, BULK INGREDIENT Regulator openFDA |
| Harbin Jixianglong Biotech Co., Ltd. | Tirzepatide, BULK INGREDIENT Regulator openFDA |
| Hubei JXBio Pharmaceutical Co.,Ltd | Tirzepatide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
| HYBIO PHARMACEUTICAL CO LTD | Tirzepatide, BULK INGREDIENT Regulator openFDA Tirzepatide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
| Medisca Inc. | Tirzepatide, BULK INGREDIENT Regulator openFDA |
| MSN Life Sciences Private Limited | Tirzepatide, BULK INGREDIENT Regulator openFDA |
| NOMIDA LLC | Tirzepatide, BULK INGREDIENT Regulator openFDA |
| Pharma Source Direct, Inc. | Tirzepatide, BULK INGREDIENT Regulator openFDA |
| Qingdao Biopeptek Co., Ltd. | Tirzepatide, BULK INGREDIENT Regulator openFDA |
| Shanghai SynTheAll Pharmaceutical Co., Ltd. | Tirzepatide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
| SHENZHEN ALVANTIS PHARMA CO LTD | Tirzepatide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
| SICHUAN JISHENG BIOPHARMACEUTICAL CO LTD | Tirzepatide, BULK INGREDIENT Regulator openFDA |
| SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD | Tirzepatide, BULK INGREDIENT Regulator openFDA Tirzepatide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
| SUZHOU LIXIN PHARMACEUTICAL CO LTD | tirzepatide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
| Thaeta Scientific LLC | Tirzepatide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
| Zhejiang Kingland Pharmaceutical Company Limited | tirzepatide, BULK INGREDIENT Regulator openFDA |
| ZHEJIANG PEPTITES BIOTECH CO LTD | Tirzepatide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
| Zhejiang Tasln Biopharma Co., Ltd. | Tirzepatide, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA |
US LABELER
5 companies
Lists a finished product with FDA (NDC directory); can be a maker, repackager or distributor.
| A-S Medication Solutions | MOUNJARO, NDA Regulator openFDA |
|---|---|
| BSP Pharmaceuticals SpA | Multiple-Dose Tirzepatide Injection, DRUG FOR FURTHER PROCESSING Regulator openFDA tirzepatide, DRUG FOR FURTHER PROCESSING Regulator openFDA |
| Eli Lilly & Company | Mounjaro KwikPen, NDA Regulator openFDA Mounjaro, NDA Regulator openFDA Zepbound KwikPen, NDA Regulator openFDA and 2 more entries |
| Eli Lilly Italia SPA | tirzepatide, DRUG FOR FURTHER PROCESSING Regulator openFDA |
| Resilience US, LLC | tirzepatide, DRUG FOR FURTHER PROCESSING Regulator openFDA Tirzepatide, DRUG FOR FURTHER PROCESSING Regulator openFDA |
TRIAL SPONSOR
138 companies
Sponsors registered clinical trials of the peptide.
| Eli Lilly & Company | 79 registered trials Trial register ClinicalTrials.gov |
|---|---|
| Brigham and Women's Hospital | 11 registered trials Trial register ClinicalTrials.gov |
| ELI LILLY AND CO | 6 registered trials Trial register EU CTIS |
| Novo Nordisk A/S | 1 registered trial Trial register EU CTIS 4 registered trials Trial register ClinicalTrials.gov |
| Dasman Diabetes Institute | 3 registered trials Trial register ClinicalTrials.gov |
| Mayo Clinic | 3 registered trials Trial register ClinicalTrials.gov |
| Nanjing First Hospital, Nanjing Medical University | 3 registered trials Trial register ClinicalTrials.gov |
| Shahid Beheshti University of Medical Sciences | 3 registered trials Trial register ClinicalTrials.gov |
| The Cleveland Clinic | 3 registered trials Trial register ClinicalTrials.gov |
| University Medical Centre Ljubljana | 3 registered trials Trial register ClinicalTrials.gov |
| University of Texas Southwestern Medical Center | 3 registered trials Trial register ClinicalTrials.gov |
| Azienda Sanitaria Locale Napoli 2 Nord | 2 registered trials Trial register ClinicalTrials.gov |
| Cambridge University Hospitals NHS Foundation Trust | 2 registered trials Trial register ClinicalTrials.gov |
| Johns Hopkins University | 2 registered trials Trial register ClinicalTrials.gov |
| Massachusetts General Hospital | 2 registered trials Trial register ClinicalTrials.gov |
| National and Kapodistrian University of Athens | 2 registered trials Trial register ClinicalTrials.gov |
| National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 2 registered trials Trial register ClinicalTrials.gov |
| Pennington Biomedical Research Center | 2 registered trials Trial register ClinicalTrials.gov |
| Rutgers, The State University of New Jersey | 2 registered trials Trial register ClinicalTrials.gov |
| Stanford University | 2 registered trials Trial register ClinicalTrials.gov |
| The University of Texas Health Science Center at San Antonio | 2 registered trials Trial register ClinicalTrials.gov |
| UNC Lineberger Comprehensive Cancer Center | 2 registered trials Trial register ClinicalTrials.gov |
| University of Colorado, Denver | 2 registered trials Trial register ClinicalTrials.gov |
| University of Southern California | 2 registered trials Trial register ClinicalTrials.gov |
| Washington University School of Medicine | 2 registered trials Trial register ClinicalTrials.gov |
| Yunlong Wang | 2 registered trials Trial register ClinicalTrials.gov |
| Zagazig University | 2 registered trials Trial register ClinicalTrials.gov |
| Akhtar Saeed Medical and Dental College | 1 registered trial Trial register ClinicalTrials.gov |
| Alaa Sada | 1 registered trial Trial register ClinicalTrials.gov |
| Ali Aminian | 1 registered trial Trial register ClinicalTrials.gov |
| Alnylam Pharmaceuticals | 1 registered trial Trial register ClinicalTrials.gov |
| Anders Fink-Jensen, MD, DMSci | 1 registered trial Trial register ClinicalTrials.gov |
| Arrowhead Pharmaceuticals | 1 registered trial Trial register ClinicalTrials.gov |
| Ascletis Pharma (China) Co., Limited | 1 registered trial Trial register ClinicalTrials.gov |
| Baylor Research Institute | 1 registered trial Trial register ClinicalTrials.gov |
| BioAge Labs, Inc. | 1 registered trial Trial register ClinicalTrials.gov |
| Biomed Industries, Inc. | 1 registered trial Trial register ClinicalTrials.gov |
| BrightGene Bio-Medical Technology Co., Ltd. | 1 registered trial Trial register ClinicalTrials.gov |
| Cardenal Herrera University | 1 registered trial Trial register ClinicalTrials.gov |
| China-Japan Friendship Hospital | 1 registered trial Trial register ClinicalTrials.gov |
Showing 40 of 138.
WARNING LETTER RECIPIENT
110 companies
Received an FDA warning letter naming the peptide.
| 24HrDoc, Inc. dba 24HrDoc | False & Misleading Claims/Misbranded (Telehealth), 2026-02-20 Regulator FDA warning letters |
|---|---|
| Alan Health Technologies Inc. dba Alan | False & Misleading Claims/Misbranded (Telehealth), 2026-02-20 Regulator FDA warning letters |
| All American Wellness | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| Altru Telehealth, LLC dba Altru Telehealth | False & Misleading Claims/Misbranded (Telehealth), 2026-06-08 Regulator FDA warning letters |
| Amie Health, Inc. dba Amie | False & Misleading Claims/Misbranded (Telehealth), 2026-06-08 Regulator FDA warning letters |
| Apothecary Pharma, LLC | Compounding Pharmacy/Adulterated Drug Products, 2025-12-01 Regulator FDA warning letters |
| Aspen Aesthetics dba Fifty 410 | False & Misleading Claims/Misbranded (Telehealth), 2026-02-20 Regulator FDA warning letters |
| Belle Health LLC dba Belle | False & Misleading Claims/Misbranded (Telehealth), 2026-02-20 Regulator FDA warning letters |
| Better Health Labs, Inc. dba Measured | False & Misleading Claims/Misbranded (Telehealth), 2026-02-20 Regulator FDA warning letters |
| Bioverse, Inc. dba Bioverse | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| Bliv Wellness LLC dba Bliv | False & Misleading Claims/Misbranded (Telehealth), 2026-02-20 Regulator FDA warning letters |
| BluefitMD | False & Misleading Claims/Misbranded (Telehealth), 2026-02-20 Regulator FDA warning letters |
| Boothwyn Pharmacy LLC | Compounding Pharmacy/Adulterated Drug Products, 2026-01-16 Regulator FDA warning letters |
| Clover Meds LLC dba Clover Meds | False & Misleading Claims/Misbranded (Telehealth), 2026-06-08 Regulator FDA warning letters |
| Curex | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| D&H Medical Services | False & Misleading Claims/Misbranded (Telehealth), 2026-06-08 Regulator FDA warning letters |
| Deluxe IV Aesthetics PLLC dba Deluxe IV and Aesthetics | False & Misleading Claims/Misbranded (Telehealth), 2026-02-20 Regulator FDA warning letters |
| directmeds.com, Inc. dba DirectMeds | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| Dr. Gater’s Weight Loss & Wellness | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| Dripgym Mobile Parent, LLC dba Amp Health | False & Misleading Claims/Misbranded (Telehealth), 2026-02-20 Regulator FDA warning letters |
| EA WORKS Limited Liability Company dba Trust Labs | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| Eden Health International Inc. dba Eden | False & Misleading Claims/Misbranded (Telehealth), 2026-06-08 Regulator FDA warning letters |
| eDrugstore | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| Elevate Your Wellness LLC, dba Elevated | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| Eli Lilly & Company | False & Misleading Claims/Misbranded, 2025-09-09 Regulator FDA warning letters |
| Empower Clinic Services, LLC dba Empower Pharmacy | CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug, 2026-09-18 Regulator FDA warning letters |
| EvoLife Wellness | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| Expert Aesthetics | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| Ezra Holdco LLC dba Ezra | False & Misleading Claims/Misbranded (Telehealth), 2026-06-08 Regulator FDA warning letters |
| Fancy Meds, LLC dba Fancy Meds | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| FITISH | False & Misleading Claims/Misbranded (Telehealth), 2026-06-08 Regulator FDA warning letters |
| FitRX, LLC dba AM RX | False & Misleading Claims/Misbranded (Telehealth), 2026-06-08 Regulator FDA warning letters |
| FitRX, LLC dba FitRx | False & Misleading Claims/Misbranded (Telehealth), 2026-02-20 Regulator FDA warning letters |
| FWD Care, Inc. dba FWD | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| Genesis Health International Inc. dba Genesis | False & Misleading Claims/Misbranded (Telehealth), 2026-02-20 Regulator FDA warning letters |
| GenLabMeds | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| GenoGenix LLC | Compounding Pharmacy/Adulterated Drug Products, 2026-01-20 Regulator FDA warning letters |
| Get.Fit.Medical, LLC dba Get.Fit.Medical | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
| Glow Medispa, LLC dba Mint Med | False & Misleading Claims/Misbranded (Telehealth), 2026-06-08 Regulator FDA warning letters |
| GLP-1 Solution | Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth), 2025-09-09 Regulator FDA warning letters |
Showing 40 of 110.
RECALLING FIRM
6 companies
Recalled a product naming the peptide (FDA enforcement report).
| AEQUITA PHARMACY | Class II recall, Ongoing, 2025-08-13 Regulator openFDA |
|---|---|
| GenoGenix LLC | Class II recall, Ongoing, 2025-10-15 Regulator openFDA |
| New Life Pharma LLC | Class II recall, Ongoing, 2026-03-11 Regulator openFDA |
| ProRx LLC | Class II recall, Ongoing, 2024-09-11 Regulator openFDA Class II recall, Ongoing, 2025-11-05 Regulator openFDA |
| Revive Rx LLC dba Revive Rx Pharmacy | Class I recall, Ongoing, 2024-06-05 Regulator openFDA Class II recall, Ongoing, 2023-05-31 Regulator openFDA |
| Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) | Class II recall, Ongoing, 2025-07-02 Regulator openFDA |
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.